Watchlist Price Alert

Enochian Biosciences Inc. (ENOB)

NASDAQ: ENOB · Real-Time Price · USD

0.71

0.01 (1.43%)

At close: Aug 04, 2023, 7:58 PM

Enochian Biosciences Income Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	121.86K	113.5K	123.59K	391.42K	366.27K	71.71K	18.48K	14.53K
Gross Profit	-121.86K	-113.5K	-123.59K	-391.42K	-366.27K	-71.71K	-18.48K	-14.53K
Operating Income	-81.64M	-38.56M	-116.08M	-23.4M	-11.92M	-10.99M	-3.24M	-2.4M
Interest Income	n/a	n/a	122.04K	13.18K	50.3K	73.49K	45.82K	n/a
Pretax Income	-80.65M	-39.68M	-113.43M	-26.85M	-11.42M	-18.02M	-6.42M	-2.21M
Net Income	-80.65M	-39.68M	-113.43M	-26.72M	-11.42M	-18.02M	-6.31M	-2.14M
Selling & General & Admin	24.56M	15.32M	14.33M	7.56M	7.12M	8.42M	2.6M	2.32M
Research & Development	2.71M	4.17M	8.37M	15.72M	4.69M	2.5M	616.96K	62.76K
Other Expenses	54.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	81.64M	19.6M	22.83M	23.4M	11.92M	10.92M	3.22M	2.39M
Interest Expense	1.01M	706.96K	372.84K	379.61K	104.28K	43.00	143.26K	26.26K
Selling & Marketing Expenses	383.55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	81.64M	19.6M	22.83M	23.4M	11.92M	10.99M	3.24M	2.4M
Income Tax Expense	n/a	706.96K	34.00	-125.28K	104.28K	1.00	-111.72K	-64.88K
Shares Outstanding (Basic)	96.25M	56.27M	52.53M	47.17M	46.33M	37.55M	21.94M	12.27M
Shares Outstanding (Diluted)	96.25M	56.27M	52.53M	47.17M	46.33M	37.55M	21.94M	12.27M
EPS (Basic)	-0.84	-0.71	-2.16	-0.57	-0.25	-0.48	-0.29	-0.17
EPS (Diluted)	-0.84	-0.71	-2.16	-0.57	-0.25	-0.48	-0.29	-0.17
EBITDA	-79.52M	-19.48M	-22.7M	-23.28M	-11.51M	-17.94M	-5.31M	-2.39M
EBIT	-79.64M	-39.1M	-113.06M	-23.4M	-11.92M	-18.02M	-5.33M	-2.4M
Depreciation & Amortization	121.86K	113.5K	123.59K	123.53K	366.27K	71.71K	18.48K	14.53K